Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy.
We retrospectively analyzed amikacin pharmacokinetics in 28 patients (mean age, 47.4 +/- 13.6 years) who received high-dose chemotherapy during a neutropenic febrile episode. Patients received an experimental protocol of high-dose anticancer chemotherapy. Amikacin pharmacokinetic parameters were cal...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1991
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245133/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1854175/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.5.944 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|